Your browser doesn't support javascript.
loading
The Severe Typhoid Fever in Africa Program: Study Design and Methodology to Assess Disease Severity, Host Immunity, and Carriage Associated With Invasive Salmonellosis.
Park, Se Eun; Toy, Trevor; Cruz Espinoza, Ligia Maria; Panzner, Ursula; Mogeni, Ondari D; Im, Justin; Poudyal, Nimesh; Pak, Gi Deok; Seo, Hyeongwon; Chon, Yun; Schütt-Gerowitt, Heidi; Mogasale, Vittal; Ramani, Enusa; Dey, Ayan; Park, Ju Yeong; Kim, Jong-Hoon; Seo, Hye Jin; Jeon, Hyon Jin; Haselbeck, Andrea; Conway Roy, Keriann; MacWright, William; Adu-Sarkodie, Yaw; Owusu-Dabo, Ellis; Osei, Isaac; Owusu, Michael; Rakotozandrindrainy, Raphaël; Soura, Abdramane Bassiahi; Kabore, Leon Parfait; Teferi, Mekonnen; Okeke, Iruka N; Kehinde, Aderemi; Popoola, Oluwafemi; Jacobs, Jan; Lunguya Metila, Octavie; Meyer, Christian G; Crump, John A; Elias, Sean; Maclennan, Calman A; Parry, Christopher M; Baker, Stephen; Mintz, Eric D; Breiman, Robert F; Clemens, John D; Marks, Florian.
Afiliação
  • Park SE; International Vaccine Institute, Seoul National University Research Park, Republic of Korea.
  • Toy T; Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.
  • Cruz Espinoza LM; International Vaccine Institute, Seoul National University Research Park, Republic of Korea.
  • Panzner U; International Vaccine Institute, Seoul National University Research Park, Republic of Korea.
  • Mogeni OD; International Vaccine Institute, Seoul National University Research Park, Republic of Korea.
  • Im J; International Vaccine Institute, Seoul National University Research Park, Republic of Korea.
  • Poudyal N; International Vaccine Institute, Seoul National University Research Park, Republic of Korea.
  • Pak GD; International Vaccine Institute, Seoul National University Research Park, Republic of Korea.
  • Seo H; Department of Microbiology and Infectious Disease, B. P. Koirala Institute of Health Sciences, Dharan, Nepal.
  • Chon Y; International Vaccine Institute, Seoul National University Research Park, Republic of Korea.
  • Schütt-Gerowitt H; International Vaccine Institute, Seoul National University Research Park, Republic of Korea.
  • Mogasale V; International Vaccine Institute, Seoul National University Research Park, Republic of Korea.
  • Ramani E; International Vaccine Institute, Seoul National University Research Park, Republic of Korea.
  • Dey A; Institute of Medical Microbiology, University of Cologne, Germany.
  • Park JY; International Vaccine Institute, Seoul National University Research Park, Republic of Korea.
  • Kim JH; International Vaccine Institute, Seoul National University Research Park, Republic of Korea.
  • Seo HJ; International Vaccine Institute, Seoul National University Research Park, Republic of Korea.
  • Jeon HJ; International Vaccine Institute, Seoul National University Research Park, Republic of Korea.
  • Haselbeck A; International Vaccine Institute, Seoul National University Research Park, Republic of Korea.
  • Conway Roy K; International Vaccine Institute, Seoul National University Research Park, Republic of Korea.
  • MacWright W; International Vaccine Institute, Seoul National University Research Park, Republic of Korea.
  • Adu-Sarkodie Y; Department of Medicine, Cambridge University, United Kingdom.
  • Owusu-Dabo E; International Vaccine Institute, Seoul National University Research Park, Republic of Korea.
  • Osei I; Global Health Institute, Emory University, Atlanta, Georgia.
  • Owusu M; Global Health Institute, Emory University, Atlanta, Georgia.
  • Rakotozandrindrainy R; School of Public Health, and, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
  • Soura AB; Kumasi Centre for Collaborative Research in Tropical Medicine, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
  • Kabore LP; International Vaccine Institute, Seoul National University Research Park, Republic of Korea.
  • Teferi M; Kumasi Centre for Collaborative Research in Tropical Medicine, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
  • Okeke IN; Kumasi Centre for Collaborative Research in Tropical Medicine, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
  • Kehinde A; Kumasi Centre for Collaborative Research in Tropical Medicine, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
  • Popoola O; University of Antananarivo, Madagascar.
  • Jacobs J; Institut Supérieur des Sciences de la Population, University of Ouagadougou, Ouagadougou, Burkina Faso.
  • Lunguya Metila O; Schiphra Hospital, Ouagadougou, Burkina Faso.
  • Meyer CG; Armauer Hansen Research Institute, ALERT Campus, Addis Ababa, Ethiopia.
  • Crump JA; Faculty of Pharmacy, University of Ibadan.
  • Elias S; Department of Medical Microbiology and Parasitology, College of Medicine, University of Ibadan.
  • Maclennan CA; Department of Medical Microbiology and Parasitology, University College Hospital.
  • Parry CM; Department of Community Medicine, College of Medicine, University of Ibadan.
  • Baker S; Department of Community Medicine, University College Hospital, Ibadan, Nigeria.
  • Mintz ED; Department of Microbiology and Immunology, KU Leuven.
  • Breiman RF; Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
  • Clemens JD; Institut National de Recherche Biomedicales, Kinshasa.
  • Marks F; Service de Microbiologie, Cliniques Universitaires de Kinshasa, Democratic Republic of Congo.
Clin Infect Dis ; 69(Suppl 6): S422-S434, 2019 10 30.
Article em En | MEDLINE | ID: mdl-31665779
ABSTRACT

BACKGROUND:

Invasive salmonellosis is a common community-acquired bacteremia in persons residing in sub-Saharan Africa. However, there is a paucity of data on severe typhoid fever and its associated acute and chronic host immune response and carriage. The Severe Typhoid Fever in Africa (SETA) program, a multicountry surveillance study, aimed to address these research gaps and contribute to the control and prevention of invasive salmonellosis.

METHODS:

A prospective healthcare facility-based surveillance with active screening of enteric fever and clinically suspected severe typhoid fever with complications was performed using a standardized protocol across the study sites in Burkina Faso, the Democratic Republic of Congo (DRC), Ethiopia, Ghana, Madagascar, and Nigeria. Defined inclusion criteria were used for screening of eligible patients for enrollment into the study. Enrolled patients with confirmed invasive salmonellosis by blood culture or patients with clinically suspected severe typhoid fever with perforation were eligible for clinical follow-up. Asymptomatic neighborhood controls and immediate household contacts of each case were enrolled as a comparison group to assess the level of Salmonella-specific antibodies and shedding patterns. Healthcare utilization surveys were performed to permit adjustment of incidence estimations. Postmortem questionnaires were conducted in medically underserved areas to assess death attributed to invasive Salmonella infections in selected sites.

RESULTS:

Research data generated through SETA aimed to address scientific knowledge gaps concerning the severe typhoid fever and mortality, long-term host immune responses, and bacterial shedding and carriage associated with natural infection by invasive salmonellae.

CONCLUSIONS:

SETA supports public health policy on typhoid immunization strategy in Africa.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por Salmonella / Febre Tifoide / Aceitação pelo Paciente de Cuidados de Saúde / Portador Sadio / Pesquisa sobre Serviços de Saúde Tipo de estudo: Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Child, preschool / Humans / Infant País como assunto: Africa Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por Salmonella / Febre Tifoide / Aceitação pelo Paciente de Cuidados de Saúde / Portador Sadio / Pesquisa sobre Serviços de Saúde Tipo de estudo: Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Child, preschool / Humans / Infant País como assunto: Africa Idioma: En Ano de publicação: 2019 Tipo de documento: Article